University of Saskatchewan
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
A
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
77%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 77 cents are available for programs.
My anchor
OVERVIEW
About University of Saskatchewan:
The University of Saskatchewan is a 5-star charity. It has above average disclosure with an A results reporting grade. It holds reserves within Ci’s reasonable range. For every dollar donated to the University of Saskatchewan, 77 cents are available to go to the cause.
A Charity Intelligence 2025 Top 100 Rated Charity.
Founded in 1907, the University of Saskatchewan (USask) is a publicly funded post-secondary institution based in Saskatoon, Saskatchewan. USask is among Canada's leading medical doctoral universities, with notable research strengths in water and food security and infectious diseases. Its alumni network spans over 177,000 members across 120 countries. Its main programs are academics and research. It spent $1.0 billion on programs in F2025, though it does not provide a breakdown of spending across its programs.
In F2025, USask had 26,648 enrolled students. This includes 21,267 undergraduate students, 4,569 graduate students, 199 non-degree students (those enrolled in individual courses without pursuing a credential), and 613 medical residents. The university operates 17 colleges and schools, offering over 80 distinct programs across more than 130 fields of study. In F2025, 17.5% of USask classes were offered in online or hybrid formats.
USask conducts research across nine signature areas: Agriculture; Communities & Sustainability; Energy & Mineral Resources for a Sustainable Future; Health & Wellness; Indigenous Peoples; One Health; Quantum Innovation; Synchrotron Sciences; and Water. In F2025, USask received $321m in research revenue and was awarded $267m in new research funding.
USask is the only university in Canada home to four flagship national research centres: VIDO (Vaccine and Infectious Disease Organization), the Canadian Light Source (Canada's only synchrotron), SuperDARN (Super Dual Auroral Radar Network), and the Global Water Futures Observatories. In F2025, it filed 29 patents and secured 31 new license agreements. Over the last five years, USask researchers have produced 675 scientific publications and presentations and tested more than 500 medicines.
My anchor
Results and Impact
USask was ranked in the 351-400 range globally in the 2025 Times Higher Education (THE) World University Rankings, and 378th in the QS 2026 World University Rankings. In the THE 2025 Impact Rankings, USask placed 101-200 overall and ranked in the global top 100 in three SDGs: Sustainable Cities and Communities (56th), Life Below Water (50th), and Partnerships for the Goals (81st). USask also ranked 131st in the QS 2025 Sustainability Rankings.
According to USask, the university increased Saskatchewan's GDP by $2.0 billion and Canada's GDP by $2.4 billion in F2025. USask-driven direct spending totalled $1.8 billion in F2025, and 33% of the province's investment in the university is returned through tax generation. 2.2% of all provincial jobs are tied in some way to USask. Each additional degree earned at USask increases average annual earnings by $13,030 for a bachelor's degree, $13,040 for a graduate degree, and $8,800 for a certificate.
Beyond its economic footprint, USask's research reaches communities worldwide. VIDO has delivered eight commercial livestock vaccines, including six global firsts, and the Crop Development Centre has released over 500 crop varieties across 40 crop types, contributing $1.2 billion in GDP, 6,938 FTE jobs, and $254 million in wages and salaries to Western Canada's economy. USask alumni include 295 Order of Canada recipients and two Nobel Prize winners in Chemistry.
While Ci highlights these key results, they may not be a complete representation of the University of Saskatchewan's results and impact. USask is not yet rated on impact (n/r). This does not affect its star rating.
My anchor
Finances
The University of Saskatchewan uses line-item costing, which is not a best practice. Ci matched the line items to each cost bucket as they best fit.
In F2025, USask earned $1.3 billion in revenue. It received $45.6m in donations (3% of total revenue), $698.3m in government funding (52% of total revenue), and $374.1m in student fees (28% of total revenue).
Administrative costs are 5% of revenues (less investment income). Fundraising costs are 18% of donations. Total overhead is 23%. For every dollar donated to the charity, 77 cents are available for programs. This is within Ci's reasonable range.
In F2025, USask spent $1.0 billion on programs, or 75% of total revenue. It recorded a $253.7m surplus and spent $124.7m on capital projects.
USask has $1.1 billion in net reserves. This includes $1.3 billion in cash and investments, less $0.1 billion in interest-bearing debt. Of this, $0.2 billion is donor-endowed. Excluding donor-endowed funds, USask could cover 94% or just over 11 months of annual program costs.
This charity update has been sent to the University of Saskatchewan for review. Changes and edits may be forthcoming. Updated by Nick Reszetnik on June 22, 2026.
Financial Review
Fiscal year ending April
|
2025 | 2024 | 2023 |
|---|---|---|---|
| Administrative costs as % of revenues | 4.8% | 5.1% | 6.8% |
| Fundraising costs as % of donations | 18.0% | 15.9% | 13.3% |
| Total overhead spending | 22.8% | 20.9% | 20.0% |
| Program cost coverage (%) | 94.2% | 85.7% | 82.5% |
Summary Financial StatementsAll figures in $000s |
2025 | 2024 | 2023 |
|---|---|---|---|
| Donations | 45,618 | 35,988 | 35,407 |
| Goods in kind | 12,988 | 25,134 | 4,855 |
| Government funding | 698,270 | 631,308 | 637,875 |
| Fees for service | 374,126 | 399,992 | 290,103 |
| Business activities (net) | 124,959 | 113,781 | 109,253 |
| Investment income | 76,840 | 98,084 | 47,725 |
| Other income | 5,316 | 4,921 | 8,074 |
| Total revenues | 1,338,117 | 1,309,208 | 1,133,292 |
| Program costs | 1,009,640 | 989,342 | 928,719 |
| Administrative costs | 60,574 | 61,438 | 73,854 |
| Fundraising costs | 8,208 | 5,703 | 4,690 |
| Other costs | 5,995 | 5,324 | 5,148 |
| Total spending | 1,084,417 | 1,061,807 | 1,012,411 |
| Cash flow from operations | 253,700 | 247,401 | 120,881 |
| Capital spending | 124,656 | 108,631 | 79,291 |
| Funding reserves | 1,113,204 | 1,007,429 | 916,119 |
Note: 1. T3010: Ci reported administrative and fundraising costs from the charity’s T3010 filings with the CRA. 2. COST OF GOODS SOLD: Ci reported sales of services and products net of cost of goods sold, affecting revenues and expenses by ($12.7m) in F2025, ($13.4m) in F2024, and ($11.3m) in F2023. 3. ENDOWMENT CONTRIBUTIONS: Ci included cash endowment contributions in donations, affecting revenues by $4.2m in F2025, $5.6m in F2024, and $7.5m in F2023. 4. INTEREST RATE SWAP: Ci removed changes in fair value of interest rate swap agreements from interest expense and included it in other income, affecting revenues and expenses by ($4.1m) in F2025, $3.9m in F2024, and $1.1m in F2023. 5. DEFERRED REVENUE: Ci adjusted for deferred revenue. This affected total revenues by $7.4m in F2025, $306k in F2024, and $12.4m in F2023.
Salary Information
$350k + |
10 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
0 |
$160k - $200k |
0 |
$120k - $160k |
0 |
$80k - $120k |
0 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2025
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 306-966-1212